CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade PROCEPT BioRobotics Corporation - PRCT CFD

    39.28
    1.63%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.12
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026207 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026207%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003985 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003985%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 39.93
    Open* 38.59
    1-Year Change* -12.4%
    Day's Range* 38.59 - 39.86
    52 wk Range 24.83-47.75
    Average Volume (10 days) 379.24K
    Average Volume (3 months) 9.45M
    Market Cap 1.70B
    P/E Ratio -100.00K
    Shares Outstanding 50.50M
    Revenue 116.39M
    EPS -2.33
    Dividend (Yield %) N/A
    Beta -100.00K
    Next Earnings Date Feb 26, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 8, 2023 39.28 0.81 2.11% 38.47 39.98 38.47
    Dec 7, 2023 39.93 1.84 4.83% 38.09 39.94 37.63
    Dec 6, 2023 38.56 -0.40 -1.03% 38.96 39.96 38.10
    Dec 5, 2023 38.94 2.48 6.80% 36.46 38.98 35.89
    Dec 4, 2023 37.96 1.74 4.80% 36.22 38.27 36.22
    Dec 1, 2023 37.34 0.67 1.83% 36.67 37.73 36.11
    Nov 30, 2023 37.02 1.52 4.28% 35.50 38.59 35.50
    Nov 29, 2023 36.96 3.21 9.51% 33.75 36.97 33.41
    Nov 28, 2023 33.73 -0.29 -0.85% 34.02 34.29 33.41
    Nov 27, 2023 34.59 -0.32 -0.92% 34.91 35.29 34.24
    Nov 24, 2023 35.18 1.05 3.08% 34.13 35.55 34.13
    Nov 22, 2023 34.64 0.67 1.97% 33.97 34.67 33.65
    Nov 21, 2023 33.65 1.17 3.60% 32.48 34.15 31.59
    Nov 20, 2023 32.95 -0.13 -0.39% 33.08 33.52 32.68
    Nov 17, 2023 32.99 -0.19 -0.57% 33.18 33.61 32.48
    Nov 16, 2023 33.41 0.68 2.08% 32.73 33.46 32.00
    Nov 15, 2023 32.83 -0.54 -1.62% 33.37 34.26 32.83
    Nov 14, 2023 33.33 0.63 1.93% 32.70 33.59 32.65
    Nov 13, 2023 32.04 2.07 6.91% 29.97 32.65 29.96
    Nov 10, 2023 30.96 -0.31 -0.99% 31.27 31.41 29.66

    PROCEPT BioRobotics Corporation Events

    Time (UTC) Country Event
    Monday, February 26, 2024

    Time (UTC)

    10:59

    Country

    US

    Event

    Q4 2023 PROCEPT BioRobotics Corp Earnings Release
    Q4 2023 PROCEPT BioRobotics Corp Earnings Release

    Forecast

    -

    Previous

    -
    Thursday, April 25, 2024

    Time (UTC)

    12:30

    Country

    US

    Event

    Q1 2024 PROCEPT BioRobotics Corp Earnings Release
    Q1 2024 PROCEPT BioRobotics Corp Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019
    Total revenue 75.014 34.473 7.717 6.169
    Revenue 75.014 34.473 7.717 6.169
    Cost of Revenue, Total 37.929 18.608 8.972 8.054
    Gross Profit 37.085 15.865 -1.255 -1.885
    Total Operating Expense 158.996 88.637 55.519 49.719
    Selling/General/Admin. Expenses, Total 88.828 51.036 30.272 28.518
    Research & Development 28.981 18.993 16.275 13.147
    Operating Income -83.982 -54.164 -47.802 -43.55
    Interest Income (Expense), Net Non-Operating -3.172 -5.753 -5.402 0.379
    Other, Net 0 0.064 0.185 1.196
    Net Income Before Taxes -87.154 -59.853 -53.019 -41.975
    Net Income After Taxes -87.154 -59.853 -53.019 -41.975
    Net Income Before Extra. Items -87.154 -59.853 -53.019 -41.975
    Net Income -87.154 -59.853 -53.019 -41.975
    Income Available to Common Excl. Extra. Items -87.154 -59.853 -53.019 -41.975
    Income Available to Common Incl. Extra. Items -87.154 -59.853 -53.019 -41.975
    Diluted Net Income -87.154 -59.853 -53.019 -41.975
    Diluted Weighted Average Shares 44.4 43.676 42.2695 42.2695
    Diluted EPS Excluding Extraordinary Items -1.96293 -1.37039 -1.25431 -0.99303
    Diluted Normalized EPS -1.88955 -1.37039 -1.25431 -0.99303
    Unusual Expense (Income) 3.258
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 33.104 24.404 23.777 20.349 16.691
    Revenue 33.104 24.404 23.777 20.349 16.691
    Cost of Revenue, Total 14.675 11.913 13.101 10.118 8.205
    Gross Profit 18.429 12.491 10.676 10.231 8.486
    Total Operating Expense 58.729 52.781 52.075 42.454 34.566
    Selling/General/Admin. Expenses, Total 32.441 30.131 26.034 24.754 19.655
    Research & Development 11.613 10.737 9.682 7.582 6.706
    Operating Income -25.625 -28.377 -28.298 -22.105 -17.875
    Interest Income (Expense), Net Non-Operating 0.34 -0.107 0.126 -0.508 -1.309
    Other, Net 0
    Net Income Before Taxes -25.285 -28.484 -28.172 -22.613 -19.184
    Net Income After Taxes -25.285 -28.484 -28.172 -22.613 -19.184
    Net Income Before Extra. Items -25.285 -28.484 -28.172 -22.613 -19.184
    Net Income -25.285 -28.484 -28.172 -22.613 -19.184
    Income Available to Common Excl. Extra. Items -25.285 -28.484 -28.172 -22.613 -19.184
    Income Available to Common Incl. Extra. Items -25.285 -28.484 -28.172 -22.613 -19.184
    Diluted Net Income -25.285 -28.484 -28.172 -22.613 -19.184
    Diluted Weighted Average Shares 45.16 45.066 44.772 44.64 44.324
    Diluted EPS Excluding Extraordinary Items -0.5599 -0.63205 -0.62923 -0.50656 -0.43281
    Diluted Normalized EPS -0.5599 -0.63205 -0.55646 -0.50656 -0.43281
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Unusual Expense (Income) 3.258
    • Annual
    • Quarterly
    2022 2021 2020 2019
    Total Current Assets 272.626 326.173 110.256 50.736
    Cash and Short Term Investments 221.859 304.32 100.13 42.021
    Cash & Equivalents 212.989 290.699 100.13 42.021
    Total Receivables, Net 15.272 4.464 1.549 1.099
    Accounts Receivable - Trade, Net 15.272 4.464 1.549 1.099
    Total Inventory 28.543 13.977 7.477 6.686
    Prepaid Expenses 6.175 2.586 0.369 0.312
    Other Current Assets, Total 0.777 0.826 0.731 0.618
    Total Assets 309.329 337.024 125.971 61.995
    Property/Plant/Equipment, Total - Net 32.137 8.324 12.915 8.273
    Property/Plant/Equipment, Total - Gross 41.141 15.018 17.703 10.515
    Accumulated Depreciation, Total -9.004 -6.694 -4.788 -2.242
    Intangibles, Net 1.477 1.75 2.023 2.295
    Other Long Term Assets, Total 3.089 0.777 0.777 0.691
    Total Current Liabilities 35.29 16.242 14.526 6.79
    Accounts Payable 9.391 2.029 1.24 1.444
    Accrued Expenses 20.682 11.205 7.824 3.132
    Notes Payable/Short Term Debt 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 4.551 0
    Other Current Liabilities, Total 5.217 3.008 0.911 2.214
    Total Liabilities 112.257 69.933 65.011 32.764
    Total Long Term Debt 51.213 50.004 44.407 23.224
    Long Term Debt 51.213 50.004 44.407 23.224
    Other Liabilities, Total 25.754 3.687 6.078 2.75
    Total Equity 197.072 267.091 60.96 29.231
    Redeemable Preferred Stock 0 0 243.854 173.068
    Common Stock 0.00045 0.00044 0.00042 0.00042
    Additional Paid-In Capital 545.753 528.666 18.788 4.808
    Retained Earnings (Accumulated Deficit) -348.675 -261.521 -201.668 -148.649
    Unrealized Gain (Loss) -0.006 -0.054 -0.014 0.004
    Other Equity, Total -0.00045 -0.00044 -0.00042 -0.00042
    Total Liabilities & Shareholders’ Equity 309.329 337.024 125.971 61.995
    Total Common Shares Outstanding 44.828 43.676 42.2695 42.2695
    Cash 8.87 13.621
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 368.668 230.016 245.58 272.626 288.932
    Cash and Short Term Investments 287.087 149.691 180.972 221.859 249.217
    Cash & Equivalents 277.784 145.756 178.333 212.989 237.14
    Total Receivables, Net 34.622 33.173 20.642 15.272 12.838
    Accounts Receivable - Trade, Net 34.622 33.173 20.642 15.272 12.838
    Total Inventory 42.201 42.636 38.926 28.543 22.358
    Prepaid Expenses 3.981 3.739 4.263 6.175 4.519
    Other Current Assets, Total 0.777 0.777 0.777 0.777
    Total Assets 421.125 272.446 284.458 309.329 324.037
    Property/Plant/Equipment, Total - Net 47.731 37.92 34.38 32.137 29.544
    Property/Plant/Equipment, Total - Gross 58.938 48.139 44.095 41.141
    Accumulated Depreciation, Total -11.207 -10.219 -9.715 -9.004
    Intangibles, Net 1.273 1.341 1.409 1.477 1.545
    Other Long Term Assets, Total 3.453 3.169 3.089 3.089 4.016
    Total Current Liabilities 41.356 35.945 32.504 35.29 27.359
    Accounts Payable 13.597 10.036 10.341 9.391 6.331
    Accrued Expenses 14.967 12.303 10.406 20.682 12.757
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases
    Other Current Liabilities, Total 12.792 13.606 11.757 5.217 8.271
    Total Liabilities 121.769 116.544 111.332 112.257 103.275
    Total Long Term Debt 51.307 51.275 51.241 51.213 50.692
    Long Term Debt 51.307 51.275 51.241 51.213 50.692
    Other Liabilities, Total 29.106 29.324 27.587 25.754 25.224
    Total Equity 299.356 155.902 173.126 197.072 220.762
    Redeemable Preferred Stock 0 0 0 0 0
    Common Stock 0.0005 0.00045 0.00045 0.00045 0.00045
    Additional Paid-In Capital 726.428 558.352 550.27 545.753 541.048
    Retained Earnings (Accumulated Deficit) -427.066 -402.444 -377.159 -348.675 -320.503
    Unrealized Gain (Loss) -0.006 -0.006 0.015 -0.006 0.217
    Other Equity, Total -0.0005 -0.00045 -0.00045 -0.00045 -0.00045
    Total Liabilities & Shareholders’ Equity 421.125 272.446 284.458 309.329 324.037
    Total Common Shares Outstanding 50.473 45.271 45.009 44.828 44.714
    Cash 9.303 3.935 2.639 8.87 12.077
    • Annual
    • Quarterly
    2022 2021 2020 2019
    Net income/Starting Line -87.154 -59.853 -53.019 -41.975
    Cash From Operating Activities -80.382 -57.334 -48.343 -43.818
    Cash From Operating Activities 2.841 3.324 2.86 1.494
    Non-Cash Items 15.418 3.902 2.299 0.195
    Cash Interest Paid 4.291 4.75 3.969 0.397
    Changes in Working Capital -11.487 -4.707 -0.483 -3.532
    Cash From Investing Activities -2.653 -0.592 -0.233 43.153
    Capital Expenditures -2.653 -0.592 -0.233 -7.611
    Other Investing Cash Flow Items, Total 0 50.764
    Cash From Financing Activities 3.612 262.116 106.771 26.527
    Issuance (Retirement) of Stock, Net 6.417 262.116 82.086 1.994
    Issuance (Retirement) of Debt, Net 1.195 0 24.685 24.533
    Net Change in Cash -79.423 204.19 58.195 25.862
    Financing Cash Flow Items -4
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -28.484 -87.154 -58.982 -36.369 -17.185
    Cash From Operating Activities -35.928 -80.382 -55.208 -35.357 -18.231
    Cash From Operating Activities 0.793 2.841 2.178 1.475 0.758
    Non-Cash Items 4.473 15.418 8.297 4.109 1.492
    Cash Interest Paid 1.121 4.291 3.573 2.369 1.171
    Changes in Working Capital -12.71 -11.487 -6.701 -4.572 -3.296
    Cash From Investing Activities -5.339 -2.653 -1.787 -0.273 -0.055
    Capital Expenditures -5.339 -2.653 -1.787 -0.273 -0.055
    Other Investing Cash Flow Items, Total
    Cash From Financing Activities 0.38 3.612 4.93 4.153 1.291
    Issuance (Retirement) of Stock, Net 0.38 6.417 4.93 4.153 1.291
    Issuance (Retirement) of Debt, Net 1.195 0
    Net Change in Cash -40.887 -79.423 -52.065 -31.477 -16.995
    Financing Cash Flow Items -4
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Fidelity Management & Research Company LLC Investment Advisor 13.0725 6582908 -46777 2023-06-30 LOW
    CPMG, Inc. Hedge Fund 10.5822 5328867 0 2023-06-30 MED
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 7.312 3682068 415432 2023-06-30 LOW
    T. Rowe Price Investment Management, Inc. Investment Advisor 6.0124 3027667 302378 2023-06-30 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 4.567 2299795 549456 2023-06-30 LOW
    T. Rowe Price Associates, Inc. Investment Advisor 2.9482 1484622 175529 2023-06-30 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 2.1104 1062730 265072 2023-06-30 LOW
    Moll (Frederic H) Individual Investor 1.7619 887233 2711 2023-06-15 LOW
    Bellevue Asset Management AG Investment Advisor 1.4725 741517 0 2023-06-30 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.4163 713191 119313 2023-06-30 LOW
    Loomis, Sayles & Company, L.P. Investment Advisor/Hedge Fund 1.4074 708704 -6688 2023-06-30 LOW
    MFS Investment Management Investment Advisor/Hedge Fund 1.3442 676872 134554 2023-06-30 LOW
    American Century Investment Management, Inc. Investment Advisor/Hedge Fund 1.1394 573761 573761 2023-06-30 LOW
    BNP Paribas Asset Management UK Limited Investment Advisor 1.1101 559025 145495 2023-09-30 MED
    Wellington Management Company, LLP Investment Advisor/Hedge Fund 1.0628 535181 0 2023-09-30 LOW
    Mirae Asset Global Investments (USA) LLC Investment Advisor 0.9898 498449 -2437 2023-09-30 LOW
    Citadel Advisors LLC Hedge Fund 0.9445 475611 -494029 2023-06-30 LOW
    Frank, Rimerman Advisors, LLC Investment Advisor 0.9074 456953 0 2023-06-30 LOW
    Johnson & Johnson Innovation-JJDC, Inc. Venture Capital 0.7108 357939 0 2023-06-30 LOW
    Mcgaughy R Kent Jr Individual Investor 0.6862 345538 117455 2022-12-05 MED

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    PROCEPT BioRobotics Corporation Company profile

    About Procept Biorobotics Corp

    Procept Biorobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). Its AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. It designs Aquablation therapy to deliver outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH that are independent of prostate size and shape or surgeon experience.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, Procept Biorobotics Corp revenues increased from $7.7M to $34.5M. Net loss increased 13% to $59.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Interest expense increase of 10% to $5.8M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$1.25 to -$1.38.

    Industry: Medical Equipment, Supplies & Distribution (NEC)

    900 Island Drive
    Suite 210
    REDWOOD CITY
    CALIFORNIA 94065
    US

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    Gold

    2,004.85 Price
    -1.180% 1D Chg, %
    Long position overnight fee -0.0198%
    Short position overnight fee 0.0116%
    Overnight fee time 22:00 (UTC)
    Spread 0.50

    US100

    16,080.90 Price
    +0.500% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 7.0

    XRP/USD

    0.67 Price
    -0.380% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    Oil - Crude

    71.41 Price
    +2.320% 1D Chg, %
    Long position overnight fee -0.0204%
    Short position overnight fee -0.0015%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading